Development and evaluation of a highly reliable assay for SUMO-specific protease inhibitors

Bioorg Med Chem Lett. 2016 May 1;26(9):2124-8. doi: 10.1016/j.bmcl.2016.03.080. Epub 2016 Mar 23.

Abstract

SUMOylation, as a post-translational modification of proteins, plays essential regulatory roles in a variety of pathological conditions. In the dynamic process of SUMOylation and deSUMOylation, SENPs (SUMO-specific proteases), in charge of deconjugation of SUMO (small ubiquitin-related modifier) from substrate proteins, have recently been found to be potential therapeutic targets for cancer treatment. A reliable and practical assay is much needed to accelerate the discovery of SENPs inhibitors. We established a quantitative assay based on readily available SDS-PAGE-Coomassie system using RanGAP-SUMO as the substrate, thus avoiding the use of expensive fluorescent dyes or the error-prone fluorescent reporter. Its reproducibility and reliability were also evaluated in this report.

Keywords: Assay; DeSUMOlyation; Inhibitor; SENP; SUMO.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzamides / analysis
  • Coloring Agents
  • Cysteine Endopeptidases / chemistry
  • Cysteine Endopeptidases / genetics
  • Enzyme Assays / methods*
  • GTPase-Activating Proteins / chemistry
  • GTPase-Activating Proteins / genetics
  • Humans
  • Hydrolysis
  • Protease Inhibitors / analysis*
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / genetics
  • Rosaniline Dyes

Substances

  • Benzamides
  • Coloring Agents
  • GTPase-Activating Proteins
  • Protease Inhibitors
  • Recombinant Fusion Proteins
  • Rosaniline Dyes
  • Coomassie blue
  • SENP1 protein, human
  • Cysteine Endopeptidases
  • SENP2 protein, human